Coronavirus Disease-2019 Vaccine Hesitancy
- PMID: 36841593
- PMCID: PMC9729588
- DOI: 10.1016/j.pcl.2022.12.001
Coronavirus Disease-2019 Vaccine Hesitancy
Abstract
Early in the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic, before coronavirus disease-2019 (COVID-19) vaccines were authorized, surveys began tracking public acceptance of a hypothetical COVID-19 vaccine. As vaccines became more widely available, the focus shifted from evaluating premeditative thoughts about COVID-19 vaccines to observing behaviors, measuring uptake, and characterizing factors associated with acceptance. A wealth of peer-reviewed literature examining the complexities of COVID-19 vaccine acceptance has emerged, but our understanding of COVID-19 vaccine acceptance is constantly evolving. In this article, we review the current state of knowledge regarding COVID-19 vaccine hesitancy, with an emphasis on pediatric vaccination.
Keywords: COVID-19; Children; Pandemic; Pediatric; SARS-CoV-2; Vaccination; Vaccine; Vaccine hesitancy.
Copyright © 2022 Elsevier Inc. All rights reserved.
References
-
- World Health Organization. Novel Coronavirus (2019-nCoV) Situation Report - 1. 2020.
-
- Ledford H., Cyranoski D., Van Noorden R. The UK has approved a COVID vaccine - here's what scientists now want to know. Nature. 2020;588(7837):205–206. - PubMed
-
- FDA Takes Key Action in Fight Against COVID-19 By Issuing Emergency Use Authorization for First COVID-19 Vaccine [press release]. December 11, 2020 2020.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous
